Phoreus Biotechnology
Olathe, US · Founded 2018 · Kansas corporation
Find your way into Phoreus Biotechnology
Sign up to see every warm intro you have to Phoreus Biotechnology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Phoreus Biotechnology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
XS
Xiomara Sinisterra-HunterNamed on SEC filing
CB
Christopher BrandtNamed on SEC filing
MC
Michael CoeNamed on SEC filing
RT
Randall ToshNamed on SEC filing
Board
SN
Scott NagleyBoard director
DS
Douglas ShaneBoard director
BA
Bill AshleyBoard director
SS
Steve SchramBoard director
MT
Matthew TomichBoard director
RP
Rajeet PannuBoard director
Reported raises · per SEC filings
Form D private placements$5.4M disclosed across 3 rounds · 2018–2025
▶$4.4MraisedMar 2026 · 49 investors · BiotechnologyRule 506(b)
▶$4.4MraisedMar 2026 · 49 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rajeet PannuDirector, Promoter
- Scott NagleyDirector
- Steve SchramDirector, Promoter
- Douglas` ShaneDirector, Promoter
- Bill AshleyDirector, Promoter
- Matthew TomichDirector, Promoter
- David SchaeferExecutive Officer, Director, Promoter
- Amount sold
- $4.4M
- Proceeds to insiders
- $1.3M
- First sale
- Jul 2020
- Incorporated
- Corporation, Kansas
- Federal exemptions
- 06b
▶$420.7KraisedMar 2026 · 3 investors · BiotechnologyRule 506(b)
▶$420.7KraisedMar 2026 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott NagleyDirector
- Douglas ShaneDirector, Promoter
- Bill AshleyDirector, Promoter
- Steve SchramDirector, Promoter
- Matthew TomichDirector, Promoter
- David SchaeferExecutive Officer, Director, Promoter
- Rajeet PannuDirector, Promoter
- Amount sold
- $420.7K
- Proceeds to insiders
- $126.3K
- First sale
- Nov 2025
- Incorporated
- Corporation, Kansas
- Federal exemptions
- 06b
▶$550KraisedDec 2019 · 7 investors · BiotechnologyRule 506(b)
▶$550KraisedDec 2019 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew TomichDirector
- Xiomara Sinisterra-HunterDirector
- Christopher BrandtDirector
- Michael CoeExecutive Officer, Director
- Randall ToshExecutive Officer, Director
- Offering amount
- $1.1M
- Amount sold
- $550K
- Minimum investment
- $50K
- Proceeds to insiders
- $218.8K
- First sale
- Jul 2018
- Incorporated
- Corporation, Kansas, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Phoreus Biotechnology raised?
- Phoreus Biotechnology has disclosed $5.4M raised across 3 rounds.
- Where is Phoreus Biotechnology headquartered?
- Phoreus Biotechnology is headquartered in Olathe, US.
